QUILIZUMAB

UNII: 26F96HRJ3W
Preferred Substance Name: QUILIZUMAB

1228538-47-3
ANTI-M1
ANTI-M1'
ANTI-M1 PRIME
HUMANIZED-MOUSE AFUCOSYLATED IGG1(.KAPPA.) AGAINST M1 PRIME SEGMENT OF MEMBRANE-BOUND IGE
IMMUNOGLOBULIN G1, ANTI-(HUMAN IMMUNOGLOBULIN E M1' FRAGMENT) (HUMAN-MOUSE MONOCLONAL MEMP1972A HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL MEMP1972A LIGHT CHAIN, DIMER
MEMP1972A
MEMP-1972A
MEP1972A
MEP-1972A
QUILIZUMAB [INN]
QUILIZUMAB [USAN]
QUILIZUMAB [WHO-DD]
RG-7449

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

QUILIZUMAB

Synonyms and Mappings

Resources

Note